Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
Top Cited Papers
- 17 November 2010
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 376 (9756), 1903-1909
- https://doi.org/10.1016/s0140-6736(10)62039-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical managementJournal of Applied Physiology, 2010
- Translational medicine: the antihypertensive effect of renal denervationAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of α1- and α2-adrenoceptors on renal sensory nerve fibersAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Hypertension Treatment and Control in Five European Countries, Canada, and the United StatesHypertension, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Renal Afferent Denervation Prevents Hypertension in Rats With Chronic Renal FailureHypertension, 1995
- Sympathetic Overactivity in Patients with Chronic Renal FailureThe New England Journal of Medicine, 1992
- Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover.Hypertension, 1988
- Noradrenaline Release And Sympathetic Nervous System ActivityJournal of Hypertension, 1985
- The Effects of Splanchnicectomy on the Blood Pressure in HypertensionCirculation, 1951